Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,924
Closed -$1.97M 362
2025
Q2
$1.97M Sell
28,924
-11,979
-29% -$759K 0.05% 161
2025
Q1
$2.48M Buy
40,903
+19,715
+93% +$1.37M 0.06% 106
2024
Q4
$1.46M Sell
21,188
-2,683
-11% -$191K 0.04% 194
2024
Q3
$1.58M Sell
23,871
-3,679
-13% -$235K 0.04% 209
2024
Q2
$1.67M Buy
27,550
+11,300
+70% +$640K 0.05% 226
2024
Q1
$926K Sell
16,250
-24,750
-60% -$1.49M 0.03% 284
2023
Q4
$2.57M Buy
41,000
+16,651
+68% +$942K 0.08% 142
2023
Q3
$1.41M Sell
24,349
-32,000
-57% -$2.02M 0.03% 292
2023
Q2
$3.51M Buy
56,349
+32,249
+134% +$2.16M 0.07% 173
2023
Q1
$1.74M Buy
+24,100
New +$1.89M 0.04% 344
2022
Q3
Sell
-27,289
Closed -$2.07M 981
2022
Q2
$2.07M Buy
27,289
+14,959
+121% +$1.14M 0.02% 640
2022
Q1
$979K Buy
+12,330
New +$897K 0.01% 702
2017
Q4
Sell
-144,100
Closed -$16.8M 330
2017
Q3
$16.8M Buy
+144,100
New +$18.2M 0.24% 86
2013
Q3
Sell
-206,000
Closed -$4.53M 502
2013
Q2
$4.53M Buy
+206,000
New +$4.5M 0.08% 253

Other funds holding INCY

UBS O'Connor's INCY Position: Q3 2025 in Review

UBS O'Connor sold out of Incyte (INCY) in Q3 2025, closing a stake of 28,924 shares — an estimated $1.97M sold.

UBS O'Connor first reported a position in INCY in Q2 2013 and held it in 14 quarters. The position peaked at $16.8M in Q3 2017. 713 funds tracked by Wall St. Rank hold INCY as of Q3 2025.

  • UBS O'Connor reported no remaining Incyte position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 28,924 Incyte shares in Q3 2025, an estimated $1.97M.
  • UBS O'Connor first reported a position in Incyte in Q2 2013 and held it in 14 quarters.
  • UBS O'Connor's Incyte position peaked at $16.8M in Q3 2017.
  • 713 funds tracked by Wall St. Rank held Incyte as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.